RAPIDO Trial Supports New Standard of Care for Advanced Rectal Cancer
Short-course radiotherapy followed by chemotherapy and total mesorectal excision improved outcomes for patients with high-risk locally advanced rectal cancer.
Short-course radiotherapy followed by chemotherapy and total mesorectal excision improved outcomes for patients with high-risk locally advanced rectal cancer.
Only a minority of clinical trials evaluating immunotherapeutic agents in 2019 used a biomarker to select patients for enrollment, a study found.
Genomic copy number instability predicted the risk of disease progression among patients with Barrett esophagus years beforehand.
A team of investigators conducted a multicenter cohort study to determine if a relationship existed between treatment for hyperthyroidism and risk of death from solid cancer.
The Consistent Testing Terminology Working Group selected plain language terminology that can be used when communicating with cancer patients about genetic testing.
The odds of developing a surgical infection after cytoreductive surgery for ovarian cancer more than doubled in women who had bowel resection or repair.
Adding cetuximab to chemotherapy led to worse outcomes for patients with resectable liver metastases caused by colorectal cancer, updated data from the New EPOC trial showed.
Preclinical and emerging clinical evidence support the possible use of AMG 510 as a single-agent KRAS (G12C) inhibitor, but preclinical evidence may also support the agent in combination.
PHGDH may be a possible target for overcoming sorafenib resistance, preclinical evidence suggests.
The study authors described the clinical benefit rate seen as similar to that reported in clinical trials.